Viveo Share (VVEO3) stock closed 9.44% higher on its debut on B3
2 min read
Viveo (Photo: Disclosure)
Monday (9) session was marked by the debut of Viveo shares (VVEO3), which saw a strong rally, although a bit away from today’s highs. VVEO3 shares closed with a strong gain of 9.44% at R$21.80. At the maximum at the start of trading, assets rose 15.36% to R$22.98.
On Thursday last week, the company priced its initial public offering (IPO) at R$19.92 per share.
Viveo is a distributor of medical products. The company was founded in 1996 by the Mafra family, who now controls the company with the Bueno family, founders of the Amil Group.
The company, whose official name is CM Hospitalar and headquartered in Ribeirão Preto (SP), was created with a focus on pharmaceutical exports and imports.
As of 2017, its growth pace has been accelerated by acquisitions, including the Flexicotton Personal Care Group, and companies such as Biogenetix, Vitalab, and Byogene for hospital products; In addition to the Far.Me segment in pharmacotherapy. The shopping list also included vaccine manufacturer Tecnocold and diaper and disposable manufacturer Cremer.
The group presents itself as a leading distributor of medical hospital materials and pharmaceuticals in Brazil and has a market share of 7%, as the company highlighted in its initial prospectus for presentation, which has 15 distribution centers in the country.
The IPO took place in August, raising R$1.8 billion in funds to invest in growth and acquisitions, as well as allowing business partners to sell shares.
(with Reuters)
In the Free Options course, Professor Su Chong Wei teaches a method for making frequent gains in the stock market. Register for free and subscribe.
Related
“Entrepreneur. Music enthusiast. Lifelong communicator. General coffee aficionado. Internet scholar.”
